company background image
ENFN logo

Enfusion NYSE:ENFN Stock Report

Last Price

US$10.07

Market Cap

US$1.3b

7D

-0.2%

1Y

9.8%

Updated

05 Jan, 2025

Data

Company Financials +

Enfusion, Inc.

NYSE:ENFN Stock Report

Market Cap: US$1.3b

ENFN Stock Overview

Provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. More details

ENFN fundamental analysis
Snowflake Score
Valuation4/6
Future Growth5/6
Past Performance1/6
Financial Health6/6
Dividends0/6

Rewards

Trading at 33% below our estimate of its fair value

Earnings are forecast to grow 74.81% per year

Risk Analysis

Profit margins (1.4%) are lower than last year (3.6%)

Large one-off items impacting financial results

Significant insider selling over the past 3 months


My Notes

Capture your thoughts, links and company narrative

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WA
Analyst Price Target
Consensus Narrative from 8 Analysts

Geographic Expansion And New Products Will Strengthen Market Position

Key Takeaways Expansion into EMEA and the Middle East is key to improving market share and client momentum. New product features and geographic growth will drive increased revenue and profitability.
View narrative
US$9.89
FV
1.8% overvalued intrinsic discount
17.47%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
3 days ago author updated this narrative

Enfusion, Inc. Competitors

Olo

NYSE:OLO

US$1.3b

Amplitude

NasdaqCM:AMPL

US$1.4b

Similarweb

NYSE:SMWB

US$1.2b

Karooooo

NasdaqCM:KARO

US$1.5b

Price History & Performance

Summary of share price highs, lows and changes for Enfusion
Historical stock prices
Current Share PriceUS$10.07
52 Week HighUS$11.38
52 Week LowUS$7.52
Beta0.95
1 Month Change-1.37%
3 Month Change12.51%
1 Year Change9.81%
3 Year Change-46.15%
5 Year Changen/a
Change since IPO-49.17%

Recent News & Updates

Enfusion: Revenue Growth Should Start To Accelerate

Dec 24

Is There An Opportunity With Enfusion, Inc.'s (NYSE:ENFN) 32% Undervaluation?

Nov 23
Is There An Opportunity With Enfusion, Inc.'s (NYSE:ENFN) 32% Undervaluation?

Recent updates

Enfusion: Revenue Growth Should Start To Accelerate

Dec 24

Is There An Opportunity With Enfusion, Inc.'s (NYSE:ENFN) 32% Undervaluation?

Nov 23
Is There An Opportunity With Enfusion, Inc.'s (NYSE:ENFN) 32% Undervaluation?

Why Private Equity Will Buyout Enfusion

Oct 29

Enfusion: Growth Should Accelerate In Coming Quarters

Aug 19

Investors Can Find Comfort In Enfusion's (NYSE:ENFN) Earnings Quality

Aug 14
Investors Can Find Comfort In Enfusion's (NYSE:ENFN) Earnings Quality

Enfusion: Expectations Of Faster Growth And Higher Margins Justify A Buy Rating

Jun 16

Is Now An Opportune Moment To Examine Enfusion, Inc. (NYSE:ENFN)?

Mar 13
Is Now An Opportune Moment To Examine Enfusion, Inc. (NYSE:ENFN)?

Capital Allocation Trends At Enfusion (NYSE:ENFN) Aren't Ideal

Feb 19
Capital Allocation Trends At Enfusion (NYSE:ENFN) Aren't Ideal

Enfusion: Product Is Sticky And Industry Is Huge

Jan 18

Calculating The Fair Value Of Enfusion, Inc. (NYSE:ENFN)

Jan 04
Calculating The Fair Value Of Enfusion, Inc. (NYSE:ENFN)

Investors Appear Satisfied With Enfusion, Inc.'s (NYSE:ENFN) Prospects As Shares Rocket 28%

Dec 02
Investors Appear Satisfied With Enfusion, Inc.'s (NYSE:ENFN) Prospects As Shares Rocket 28%

Enfusion: Still Bullish Considering Q3 EBITDA Beat

Nov 08

Why Enfusion, Inc. (NYSE:ENFN) Could Be Worth Watching

Oct 31
Why Enfusion, Inc. (NYSE:ENFN) Could Be Worth Watching

Enfusion Faces Cross-Currents In Investment Management Software Market

Aug 24

Enfusion, Inc. Just Missed Earnings - But Analysts Have Updated Their Models

Aug 11
Enfusion, Inc. Just Missed Earnings - But Analysts Have Updated Their Models

Enfusion: Multiple Catalysts

Jun 20

Enfusion, Inc.'s (NYSE:ENFN) Intrinsic Value Is Potentially 32% Above Its Share Price

Mar 08
Enfusion, Inc.'s (NYSE:ENFN) Intrinsic Value Is Potentially 32% Above Its Share Price

Here's Why We're Not At All Concerned With Enfusion's (NYSE:ENFN) Cash Burn Situation

Feb 08
Here's Why We're Not At All Concerned With Enfusion's (NYSE:ENFN) Cash Burn Situation

Enfusion brings on Shift4 Payments' Brad Herring as CFO

Dec 19

Enfusion Expands Offerings As Revenue Growth Decelerates

Oct 31

Enfusion, Inc. (NYSE:ENFN) Shares Could Be 49% Below Their Intrinsic Value Estimate

Oct 18
Enfusion, Inc. (NYSE:ENFN) Shares Could Be 49% Below Their Intrinsic Value Estimate

Enfusion gains after takeover report

Aug 31

Shareholder Returns

ENFNUS SoftwareUS Market
7D-0.2%-1.1%-0.2%
1Y9.8%23.1%25.8%

Return vs Industry: ENFN underperformed the US Software industry which returned 23.1% over the past year.

Return vs Market: ENFN underperformed the US Market which returned 25.8% over the past year.

Price Volatility

Is ENFN's price volatile compared to industry and market?
ENFN volatility
ENFN Average Weekly Movement4.5%
Software Industry Average Movement7.9%
Market Average Movement6.4%
10% most volatile stocks in US Market18.6%
10% least volatile stocks in US Market3.1%

Stable Share Price: ENFN has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: ENFN's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19971,102Oleg Movchanwww.enfusion.com

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services.

Enfusion, Inc. Fundamentals Summary

How do Enfusion's earnings and revenue compare to its market cap?
ENFN fundamental statistics
Market capUS$1.29b
Earnings (TTM)US$2.73m
Revenue (TTM)US$195.16m

348.4x

P/E Ratio

4.9x

P/S Ratio

Is ENFN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ENFN income statement (TTM)
RevenueUS$195.16m
Cost of RevenueUS$64.10m
Gross ProfitUS$131.06m
Other ExpensesUS$128.33m
EarningsUS$2.73m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.029
Gross Margin67.16%
Net Profit Margin1.40%
Debt/Equity Ratio0%

How did ENFN perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 03:36
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Enfusion, Inc. is covered by 12 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Koji IkedaBofA Global Research
Kevin McVeighCredit Suisse
Parth TalsaniaEquisights